Custom Heavy Peptides
Medchemexpress LLC MAGE-A1-derived peptide acetate | 99.6% | 1270.51 | 5 MG
MAGE-A1-derived peptide acetate is a short peptide sequence derived from the MAGE-A1 protein. It functions as a tumor-specific antigen, capable of being recognized and activated by cytotoxic T lymphocytes (CTLs). This activation initiates an immune response against tumor cells that express MAGE-A1, ultimately leading to their lysis and death. This compound is valuable for research in tumor immunity.
- Derived from MAGE-A1 protein.
- Acts as a tumor-specific antigen.
- Activates cytotoxic T lymphocytes (CTLs).
- Generates an immune response against MAGE-A1 expressing tumor cells.
- Induces tumor cell lysis and death.
- Used in tumor immunity studies.
Cayman Chemical L-TyrosIn-13C9 15N 50mg
An internal standard for the quantification of L-tyrosine by GC- or LC-MS
Medchemexpress LLC Insulin β Chain Peptide (15-23) | 247044-67-3 | 95.7% | 1009.18 | 5 MG
Insulin β Chain Peptide (15-23) is one of the earliest antigenic epitopes to which CD8 T-cells respond. This peptide is for research use only and not intended for patient use. It is a white to off-white solid with a purity of 95.68%.
- Exhibits high purity at 95.68%
- For research use only
- Stimulates IFN-γ and TNF-α production in CD8 T-cells in vitro
- Promotes rapid diabetes development in specific mouse models in vivo
- White to off-white solid appearance
- Features amino acid sequence Leu-Tyr-Leu-Val-Cys-Gly-Glu-Arg-Gly (LYLVCGERG)
Cayman Chemical ANTIBODY HS-1371 50mg
A RIPK3 inhibitor (IC50 = 20.8 nM); inhibits basal RIPK3 autophosphorylation and TNF-α- or TRAIL-induced necroptosis in HT-29 cells at 5 µM; inhibits TNF-α Smac mimetic- and Z-VAD-induced necroptosis in HeLa and NCI-H2009 cancer cells ectopically expressing RIPK3
Cayman Chemical L-TyrosIn-13C9 15N 100mg
An internal standard for the quantification of L-tyrosine by GC- or LC-MS
Sigma Aldrich Fine Chemicals Biosciences BUFRD SDM CHLOR PEPT SOLN 10PK
NC3672524 BUFRD SDM CHLOR PEPT SOLN 10PK
Cayman Chemical 3-BromotyrosIn-13C9 15NtrI 1mg
An internal standard for the quantification of 3-bromotyrosine
Cayman Chemical 15Lipoxygenase2 Blocking Pept
Immunogen: Synthetic peptide from the internal region of 15-LO-2 · To be used in conjunction with Cayman’s 15-LO-2 polyclonal antibody (Catalog No. 10004454) to block protein-antibody complex formation during immunochemical analysis of 15-LO-2.
Cayman Chemical 3-BromotyrosIn-13C9 15NtrI 5mg
An internal standard for the quantification of 3-bromotyrosine
Cayman Chemical L-ThyroxIn-13C9 15N 1mg
An internal standard for the quantification of L-thyroxine by GC- or LC-MS
Medchemexpress LLC Rage antagonist peptide | 1092460-91-7 | 98.2% | 1272.55 | 1 MG
RAGE antagonist peptide is an advanced glycation end products (RAGE) antagonist. It works by preventing RAGE from binding with several of its key ligands, including HMGB-1, S100P, and S100A4. This peptide also exhibits anti-tumor and anti-inflammatory activities.
- Prevents RAGE from binding with several important ligands (HMGB-1, S100P, S100A4)
- Exhibits anti-tumor activities
- Exhibits anti-inflammatory activities
- Reduces NFκB activation in cancer cells
- Inhibits glioma tumor growth
- Blunts airway reactivity, airway inflammation, and goblet cell metaplasia in asthma models
Cayman Chemical L-TyrosIn-13C9 15N 250mg
A histamine H1 receptor antagonist (IC50 180 nM) selective for the histamine H1 receptor in a panel of 30 receptors in vitro at 100 UM prevents microvascular extravasation (ED50 185 Ug/kg i v ) bronchospasm (ED50 4 6 Ug/kg i v ) and systemic anaphylaxis (ED50 0 2 Ug/kg p o ) induced by subcutaneous histamine in guinea pigs prevents anaphylaxis induced by subcutaneous administration of ovalbumin or DNP in sensitized rats at 7 6 and 6 0 mg/kg respectively
Cayman Chemical L-TyrosIn-13C9 15N 25mg
An internal standard for the quantification of L-tyrosine by GC- or LC-MS
- 1
- 2